Search results
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Zacks via Yahoo News· 3 weeks agoRegeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo News· 2 months agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo News· 2 months agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
Pharma Stock Roundup: FDA Nod to Updated PFE, MRNA COVID Jabs, & More
Zacks via Yahoo News· 10 months agoThe FDA authorizes Pfizer (PFE) and Moderna's (MRNA) updated mRNA-based COVID-19 vaccines. Novo...
Sanofi's (SNY) Dupixent Gets EU Nod for Eczema in Young Kids
Zacks via Yahoo News· 1 year agoSanofi (SNY) and Regeneron's Dupixent becomes the first and only targeted medicine approved to treat...
Regeneron (REGN) Posts Upbeat Data From Multiple Myeloma Study
Zacks via Yahoo News· 1 year agoA mid-stage study data shows that treatment with Regeneron's (REGN) experimental antibody achieved a...
Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7%
Zacks via Yahoo News· 1 year agoRegeneron's (REGN) share price rose after it reported data from a late-stage study showing that...
FDA Accepts Sanofi's (SNY) sBLA for Dupixent in Pediatric EoE
Zacks via Yahoo News· 10 months agoIf this filing is approved, Sanofi (SNY)/Regeneron's (REGN) Dupixent will be the first FDA-approved...
Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More
Zacks via Yahoo News· 7 months agoIt has been a busy week for the biotech sector, with a lot of updates on collaborations, study...
argenx (ARGX) Tanks on Top-Line Data From Pemphigus Study
Zacks via Yahoo News· 7 months agoargenx's (ARGX) phase III ADDRESS study, evaluating efgartigimod subcutaneous for treating...